Last reviewed · How we verify

NCT03371225

Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System

Completed NA Results posted Last updated 10 December 2025
What this trial tests

NA trial testing Active tDCS in Fibromyalgia in 116 participants. Completed in 26 October 2025.

Timeline
1 May 2019
Primary endpoint
26 September 2024
26 October 2025

Quick facts

Lead sponsorSpaulding Rehabilitation Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingtriple
Primary purposeother
Enrollment116
Start date1 May 2019
Primary completion26 September 2024
Estimated completion26 October 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Spaulding Rehabilitation Hospital

Who can join

Adults 18 to 65, any sex, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Conditioning Pain Modulation (CPM) Primary · 6 weeks

Pain intensity was measured using the Numeric Pain Scale (NPS; 0 = no pain, 10 = worst pain). Higher scores indicate worse pain. A "pain-6 temperature" was first identified (temperature that elicits NPS = 6). Test stimulus: Pain-6 temperature applied for 30s; participants rated pain at 10, 20, and 30s. The test-stimulus score is the average of the three NPS ratings. Conditioned stimulus: After 5 minutes, the left hand was immersed in 10-12°C water for 30s while the same pain-6 temperature was applied again. Pain was rated the same way, and the conditioned-stimulus score is the average of the

GroupValue95% CI
Active tDCS and Active Exercise0.36-0.23 – 0.95
Sham tDCS and Active Exercise0.05-0.63 – 0.73
Active tDCS and Sham Exercise0.21-0.40 – 0.83
Sham TDCS and Sham Exercise-0.55-1.01 – -0.09
Temporal Slow Pain Summation (TSPS) Primary · 6 weeks

Participants first determined the temperature that elicited Numeric Pain Scale (NPS) = 6 ("pain-6"). Using this temperature, a train of 15 heat pulses (0.4 Hz) was delivered to the right forearm with a TSA-II thermode. Pain was rated using the NPS after the 1st and 15th heat stimulus. TSPS calculation: TSPS = NPS rating after the 15th stimulus - NPS rating after the 1st stimulus. Higher TSPS values represent greater temporal pain summation (worse outcome).

GroupValue95% CI
Active tDCS and Active Exercise-0.11-0.60 – 0.38
Sham tDCS and Active Exercise0.48-0.29 – 1.25
Active tDCS and Sham Exercise0.47-0.27 – 1.20
Sham TDCS and Sham Exercise0.09-0.44 – 0.61

Adverse events — posted to ClinicalTrials.gov

Time frame: 4.5 months. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Active tDCS and Active Exercise
Serious: 0/28 (0%)
Deaths: 0/28
Sham tDCS and Active Exercise
Serious: 0/28 (0%)
Deaths: 0/28
Active tDCS and Sham Exercise
Serious: 0/30 (0%)
Deaths: 0/30
Sham TDCS and Sham Exercise
Serious: 1/30 (3%)
Deaths: 0/30

Serious adverse events (1 terms)

ReactionSystemActive tDCS and Active Exe…Sham tDCS and Active Exerc…Active tDCS and Sham Exerc…Sham TDCS and Sham Exercise
Allergic reactionSkin and subcutaneous tissue disorders
Other adverse events (1 terms — click to expand)

ReactionSystemActive tDCS and Active Exe…Sham tDCS and Active Exerc…Active tDCS and Sham Exerc…Sham TDCS and Sham Exercise
Mild TinglingSkin and subcutaneous tissue disorders

Most-reported serious reactions: Allergic reaction.

Data from ClinicalTrials.gov NCT03371225 adverse events section.

Sponsor's own description

This trial aims at understanding the mechanisms of optimized transcranial direct current stimulation (tDCS) (16 tDCS sessions combined with exercise)\] on pain control. Optimized tDCS can lead to stronger engagement of the endogenous pain regulatory system that will ultimately lead to increased pain relief in patients with fibromyalgia (FM). Therefore, the investigators designed a 2x2 factorial mechanistic trial \[tDCS (active and sham) and aerobic exercise (AE) (active and control)\] to evaluate the effects of 4 weeks of tDCS coupled with exercise on the endogenous pain regulatory system assessed by conditioned pain modulation (CPM) and central sensitization as assessed by temporal slow pain summation (TSPS), and compared to either intervention alone and to no intervention.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Decreased neural inhibitory state in fibromyalgia pain: A cross-sectional study.
    Uygur-Kucukseymen E, Castelo-Branco L, Pacheco-Barrios K, Luna-Cuadros MA, et al · · 2020 · cited 31× · PMID 32654884 · DOI 10.1016/j.neucli.2020.06.002
  2. Optimised transcranial direct current stimulation (tDCS) for fibromyalgia-targeting the endogenous pain control system: a randomised, double-blind, factorial clinical trial protocol.
    Castelo-Branco L, Uygur Kucukseymen E, Duarte D, El-Hagrassy MM, et al · · 2019 · cited 31× · PMID 31672712 · DOI 10.1136/bmjopen-2019-032710
  3. Temporal Summation in Fibromyalgia Patients: Comparing Phasic and Tonic Paradigms.
    Castelo-Branco L, Cardenas-Rojas A, Rebello-Sanchez I, Pacheco-Barrios K, et al · · 2022 · cited 11× · PMID 35812016 · DOI 10.3389/fpain.2022.881543
  4. High Body Mass Index Disrupts the Homeostatic Effects of Pain Inhibitory Control in the Symptomatology of Patients With Fibromyalgia.
    Lacerda GJM, Pacheco-Barrios K, Fregni F. · · 2024 · cited 8× · PMID 39374799 · DOI 10.1016/j.jpain.2024.104691
  5. Adaptive and Compensatory Neural Signatures in Fibromyalgia: An Analysis of Resting-State and Stimulus-Evoked EEG Oscillations.
    Camargo L, Pacheco-Barrios K, Marques LM, Caumo W, et al · · 2024 · cited 7× · PMID 39062001 · DOI 10.3390/biomedicines12071428
  6. Cross-sectional and longitudinal analysis of conditioned pain modulation and pain in fibromyalgia: CPM as an effect modifier of pain changes over time.
    Castelo-Branco L, Pacheco-Barrios K, Cardenas-Rojas A, de Melo PS, et al · · 2024 · cited 7× · PMID 39055778 · DOI 10.1002/pri.2072
  7. Brain compensatory mechanisms in depression and memory complaints in fibromyalgia: the role of theta oscillatory activity.
    Pacheco-Barrios K, Teixeira PEP, Martinez-Magallanes D, Neto MS, et al · · 2024 · cited 7× · PMID 38652585 · DOI 10.1093/pm/pnae030
  8. Motor Cortex Inhibition and Facilitation Correlates with Fibromyalgia Compensatory Mechanisms and Pain: A Cross-Sectional Study.
    Pacheco-Barrios K, Pimenta DC, Pessotto AV, Fregni F. · · 2023 · cited 3× · PMID 37371638 · DOI 10.3390/biomedicines11061543

Verify or expand the search:

Other trials of Active tDCS

Trials testing the same drug.

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Spaulding Rehabilitation Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03371225.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing